The health chain misled investors about how the Omnicare acquisition had led to “rising costs and poor results,” eating into the company’s finances, according to the suit filed in the U.S. District court for the Southern District of New York.
CVS meant for the Omnicare purchase to grow its ability to reach assisted living and long-term care facilities, the complaint says. But those facilities have seen their own finances deteriorate as occupancy ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.